Keyword: Ultomiris (ravulizumab-cwvz)

Drugs and money sign

The top 10 drug launches of 2019

Cancer is probably the most sought-after indication in the biopharma world, but it’s missing from the 2019 class of top drug launches. Instead, treatments in immunology and rare genetic diseases have grabbed the limelight.